NSTEMI - Non-ST Segment Elevation MI: Clinical Trials

6 trials for NSTEMI - Non-ST Segment Elevation MI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1

Follow NSTEMI - Non-ST Segment Elevation MI: new trials by email Literature Review of NSTEMI - Non-ST Segment Elevation MI trials Research Report on NSTEMI - Non-ST Segment Elevation MI

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
30-day DAPT, Guideline-directed therapy - Acute Coronary Syndrome, Myocardial Infarction
Phase 4RecruitingSt. Antonius Hospital20002023-01-112023-12-15
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
Evolocumab 140 MG/ML, Standard of care (SOC) - STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI
Phase 4Active not recruitingAssistance Publique - Hôpitaux de Paris21662021-09-292026-04-13
Implementing Precision Medicine Approaches to Guide Anti-platelet Selection
CYP2C19 genotyping - Acute Coronary Syndrome (ACS), STEMI - ST Elevation Myocardial Infarction (MI)
Phase 4UnknownUniversity of Southern California2002020-03-132021-09-28
Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg
Clopidogrel - Diabetes Mellitus, Type 2, NSTEMI - Non-ST Segment Elevation MI
Phase 4CompletedLaboratoires Teriak1672017-12-072019-12-23
Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
Regular management+Levosimendan - Early Management, Acute Heart Failure
Phase 4UnknownQilu Hospital of Shandong University4702017-07-012021-07-19
Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction
Clopidogrel, Ticagrelor - Acute Coronary Syndrome, STEMI
Phase 4CompletedUniversity of Zagreb1202015-12-012020-04-30

Narrower conditions

Non-ST Elevated Myocardial Infarction (6)  ·  ST Elevation Myocardial Infarction (4)  ·  Acute Coronary Syndrome (3)  ·  Angina, Unstable (1)  ·  Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Embolism (1)  ·  Hemorrhage (1)  ·  Myocardial Infarction (1)  ·  Stroke (1)  ·  Thrombosis (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Heart Diseases (6)  ·  Infarction (6)  ·  Ischemia (6)  ·  Myocardial Ischemia (6)  ·  Necrosis (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Vascular Diseases (6)  ·  Myocardial Infarction (5)  ·  Angina Pectoris (1)  ·  Arrhythmias, Cardiac (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Brain Diseases (1)

Interventions

Clopidogrel (2)  ·  2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1)  ·  Standard of Care (1)  ·  Ticagrelor (1)  ·  evolocumab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Laboratoires Teriak (1)  ·  Qilu Hospital of Shandong University (1)  ·  St. Antonius Hospital (1)  ·  University of Southern California (1)  ·  University of Zagreb (1)

Countries

Belgium (1)  ·  China (1)  ·  Croatia (1)  ·  France (1)  ·  Netherlands (1)  ·  Tunisia (1)  ·  United States (1)

Top investigators

Scott A Mosley, PharmD (1)

Results publications

PMID 39007830, PMID 42666092